424
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Preferences for psychological therapy in psychosis: trial participation, mode of treatment, and willingness to be randomised

, , , , , , & show all
Pages 67-71 | Received 30 Aug 2012, Accepted 10 Jul 2013, Published online: 12 Dec 2013

References

  • American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, 4th ed, text revision. Washington, DC: American Psychiatric Association
  • Bedi N, Chilvers C, Churchill R, et al. (2000). Assessing effectiveness of treatment of depression in primary care. Br J Psychiatr, 177, 312–18
  • Bellack AS. (2006). Scientific and consumer models of recovery in schizophrenia: Concordance, contrasts, and implications. Schizophrenia Bull, 32, 432–42
  • Bernard HR, Ryan GW. (2010). Analyzing qualitative data: Systematic approaches. Thousand Oaks (CA): Sage
  • Bradley C. (1996). Patients' preferences and randomised trials. Lancet, 347, 1118–19
  • Brewin CR, Bradley C. (1989). Patient preferences and randomised clinical trials. Br Med J, 299, 313–15
  • Brocklehurst P. (1997). Partially randomised patient preference trials. Br J Obstet Gynaecol, 104, 1332–5
  • Byrne R, Davies L, Morrison AP. (2010). Priorities and preferences for the outcomes of treatment of psychosis: A service user perspective. Psychosis, 2, 210–17
  • Department of Health. (1999). Involvement works. The second report of the Standing Group on Consumers in NHS Research. London: Department of Health
  • Department of Health. (2001). Treatment choice in psychological therapies and counselling. London: HMSO
  • Featherstone K, Donovan JL. (1998). Random allocation or allocation at random? Patients' perspectives of participation in a randomised controlled trial. Br Med J, 317, 1177–80
  • Gemmell I, Dunn G. (2011). The statistical pitfalls of the partially randomized preference design in non-blinded trials of psychological interventions. Int J Meth Psychiatr Res, 20, 1–9
  • Haddock G, Spaulding W. (2011). Psychological treatment of psychosis. In: Weinberger DR, Harrison PJ, eds. Schizophrenia. Oxford: Wiley-Blackwell, 666--86
  • Halpern SD, Metzger DS, Berlin JA, Ubel PA. (2001). Who will enroll? Predicting participation in a phase II AIDS vaccine trial. J Acq Immun Def Syndr, 27, 281–8
  • Howard L, Thornicroft G. (2006). Patient preference randomised controlled trials in mental health research. Br J Psychiatr, 188, 303–4
  • Janevic MR, Janz NK, Dodge JA, et al. (2003). The role of choice in health education intervention trials: A review and case study. Soc Sci Med, 56, 1581–94
  • Kay SR, Fiszbein A, Opler LA. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bull, 13, 261–76
  • King M, Nazareth I, Lampe F, et al. (2005). Impact of participant and physician intervention preferences on randomized trials: A systematic review. J Am Med Assoc, 293, 1089–99
  • Kovnick JA, Appelbaum PS, Hoge SK, Leadbetter RA. (2003). Competence to consent to research among long-stay inpatients with chronic schizophrenia. Psychiatr Serv, 54, 1247–52
  • Krippendorff K. (1984). Content analysis: An introduction to its methodology. J Am Stat Assoc, 79, 240
  • Lilford RJ. (2003). Ethics of clinical trials from a bayesian and decision analytic perspective: Whose equipoise is it anyway? Br Med J, 326, 980–1
  • Locock L, Smith L. (2011). Personal benefit, or benefiting others? Deciding whether to take part in clinical trials. Clin Trials, 8, 85–93
  • Lovell K, Cox D, Haddock G, et al. (2006). Telephone administered cognitive behaviour therapy for treatment of obsessive compulsive disorder: Randomised controlled non-inferiority trial. Br Med J, 333, 883–6
  • National Institute for health And Clinical Excellence. (2009). Schizophrenia. Core interventions in the treatment and management of schizophrenia in primary and secondary care. Clinical guideline 82. London: NICE
  • Pitt L, Kilbride M, Nothard S, et al. (2007). Researching recovery from psychosis: A user-led project. Psychiatr Bull, 31, 55–60
  • Roberts LW, Warner TD, Brody JL, et al. (2002). Patient and psychiatrist ratings of hypothetical schizophrenia research protocols: Assessment of harm potential and factors influencing participation decisions. Am J Psychiatr, 159, 573–84
  • Roberts LW, Warner TD, Hammond KG, Hoop JG. (2006). Views of people with schizophrenia regarding aspects of research: Study size and funding sources. Schizophrenia Bull, 32, 107–15
  • Ross S, Grant A, Counsell C, et al. (1999). Barriers to participation in randomised controlled trials: A systematic review. J Clin Epidemiol, 52, 1143–56
  • Ward E, King M, Lloyd M, et al. (2000). Randomised controlled trial of non-directive counselling, cognitive-behaviour therapy, and usual general practitioner care for patients with depression. I: Clinical effectiveness. Br Med J, 321, 1383–8
  • World Health Organization. (1992). The ICD-10 classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. Geneva: World Health Organization
  • Yanos PT, Moos RH. (2007). Determinants of functioning and well-being among individuals with schizophrenia: An integrated model. Clin Psychol Rev, 27, 58–77
  • Zullino D, Conus P, Borgeat F, Bonsack C. (2003). Readiness to participate in psychiatric research. Can J Psychiatr, 48, 480–4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.